APA (7th ed.) Citation

Y, G., Y, S., C, W., R, X., X, B., S, L., . . . Q, H. (2026). OTU deubiquitinases as immune-circuit editors: From human immunopathology to therapeutic prioritization. Frontiers in immunology, 17, 1843621. https://doi.org/10.3389/fimmu.2026.1843621

Chicago Style (17th ed.) Citation

Y, Guo, et al. "OTU Deubiquitinases as Immune-circuit Editors: From Human Immunopathology to Therapeutic Prioritization." Frontiers in Immunology 17 (2026): 1843621. https://doi.org/10.3389/fimmu.2026.1843621.

MLA (9th ed.) Citation

Y, Guo, et al. "OTU Deubiquitinases as Immune-circuit Editors: From Human Immunopathology to Therapeutic Prioritization." Frontiers in Immunology, vol. 17, 2026, p. 1843621, https://doi.org/10.3389/fimmu.2026.1843621.